The company ALAPIS S.A., announces the investment public, in continuation of its announcement, regarding its participation in the competition for the privatization of the company SUMADIJALEK S.A. in Serbia, through the sale of of 68.25% of its share capital, according to the declaration of the 'Privatization Agency of the Republic of Serbia', that it has been pre-elected as the highest bidder with a total price that amounts to Euro 2.18 mil. The initiation of the negotiations will follow between the company and the 'Privatization Agency of the Republic of Serbia', with the purpose of the sign of the contract of the purchase.
SUMADIJALEK S.A. was founded in 1965 and is activated in the distribution of human medicine and other parapharmaceutical products, with a turnover of 9.4 mil. Euro for 2005.
According to figures of 2005, 48% of the sales comes from public hospitals, clinics, pharmacies e.t.c., while the rest of it comes from the private sector.
The company cooperates with almost all the local medicine producers and is a direct importer of Bayer and Boehringer products.